Clinical significance and biological roles of TRIM24 in human bladder carcinoma (Q38890406)

7 September 2017

title

Clinical significance and biological roles of TRIM24 in human bladder carcinoma (English)

1 reference

7 September 2017

Dongwei Xue

1

1 reference

7 September 2017

Xiuwei Zhang

2

1 reference

7 September 2017

Xilin Zhang

3

1 reference

7 September 2017

Jia Liu

4

1 reference

7 September 2017

Ning Li

5

1 reference

7 September 2017

Chunlai Liu

6

1 reference

7 September 2017

Yili Liu

7

1 reference

7 September 2017

Ping Wang

8

1 reference

7 September 2017

publication date

7 April 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

9

1 reference

7 September 2017

page(s)

6849-6855

1 reference

7 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Increased SPHK1 expression is associated with poor prognosis in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Clinical significance of UNC5B expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

TIF1 alpha: a chromatin-specific mediator for the ligand-dependent activation function AF-2 of nuclear receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

TRIM24 links a non-canonical histone signature to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Overexpression of TRIM24 correlates with tumor progression in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Regulation of cyclin D1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Clinical significance and biological roles of CARMA3 in human bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3393-3

TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25846736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25846736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25846736

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-015-3393-3

1 reference

Dimensions Publication ID

7 September 2017

1040990887

0 references

1 reference